Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Peter Hartman spoke to Rapidus about investment promotion and the new joint microbiome project with Copenhagen Capacity and Invbest in Skåne.
JT develops pharmaceutical therapies for metabolic diseases, autoimmune/inflammatory diseases and viral infection. In 2018, JT reported net sales of 114 billion yen (€ 1 billion) and close to 40 billion yen (€ 330M) R&D investment with 2,000 employees in its pharmaceutical business.
SmiLe Incubator is a business incubator located at Medicon Village in Lund, Sweden. We help entrepreneurs and early stage companies in the life sciences develop and commercialize new ideas.
Click here to read more about us!JT develops pharmaceutical therapies for metabolic diseases, autoimmune/inflammatory diseases and viral infection. In 2018, JT reported net sales of 114 billion yen (€ 1 billion) and close to 40 billion yen (€ 330M) R&D investment with 2,000 employees in its pharmaceutical business.
SmiLe Incubator is a business incubator located at Medicon Village in Lund, Sweden. We help entrepreneurs and early stage companies in the life sciences develop and commercialize new ideas.
Click here to read more about us!
